Literature DB >> 35272055

The Care of Adolescents and Young Adults with Turner Syndrome: A Pediatric and Adolescent Gynecology Perspective.

Tazim Dowlut-McElroy1, Roopa Kanakatti Shankar2.   

Abstract

Turner syndrome (TS) is caused by the absence of a part or whole X chromosome in a phenotypic female and has an estimated prevalence of 25-50/100,000 live-born females. The primary gynecologic manifestation of TS is primary ovarian insufficiency (POI), and the resulting hypoestrogenism and infertility are experienced by most individuals with TS. In this review, we summarize the recommendations for the care of adolescents and young adults with TS, with a focus on primary ovarian insufficiency in TS, hormone replacement therapy, fertility preservation, and pregnancy in TS.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  DSD; Fertility; Hormone replacement therapy; POI; Pregnancy complications; Preservation; Pubertal induction; Turner syndrome

Mesh：

Year:  2022        PMID： 35272055      PMCID： PMC9288983          DOI： 10.1016/j.jpag.2022.02.002

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN： 1083-3188            Impact factor:   2.046


  80 in total

Review 1.  Sex hormone replacement therapy for individuals with Turner syndrome.

Authors:  Philippe Backeljauw; Karen Klein
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-02-26       Impact factor: 3.908

2.  Fertility and pregnancy outcome in Danish women with Turner syndrome.

Authors:  N H Birkebaek; D Crüger; J Hansen; J Nielsen; G Bruun-Petersen
Journal:  Clin Genet       Date:  2002-01       Impact factor: 4.438

Review 3.  To Freeze or Not to Freeze? An Update on Fertility Preservation In Females with Turner Syndrome.

Authors:  M J Schleedoorn; A A E M van der Velden; D D M Braat; R Peek; K Fleischer
Journal:  Pediatr Endocrinol Rev       Date:  2019-03

4.  Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

Authors:  Judith L Ross; Charmian A Quigley; Dachuang Cao; Penelope Feuillan; Karen Kowal; John J Chipman; Gordon B Cutler
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

Review 5.  Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations.

Authors:  Karen O Klein; Robert L Rosenfield; Richard J Santen; Aneta M Gawlik; Philippe F Backeljauw; Claus H Gravholt; Theo C J Sas; Nelly Mauras
Journal:  J Clin Endocrinol Metab       Date:  2018-05-01       Impact factor: 5.958

6.  Dysgerminoma in a 10-Year Old with 45X/46XY Turner Syndrome Mosaicism.

Authors:  Tazim Dowlut-McElroy; Denise A Vilchez; Eugenio M Taboada; Julie L Strickland
Journal:  J Pediatr Adolesc Gynecol       Date:  2019-07-04       Impact factor: 1.814

7.  Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles.

Authors:  Birgit Borgström; Borgström Birgit; Julius Hreinsson; Hreinsson Julius; Carsten Rasmussen; Rasmussen Carsten; Maryam Sheikhi; Sheikhi Maryam; Gabriel Fried; Fried Gabriel; Victoria Keros; Keros Victoria; Margareta Fridström; Fridström Margareta; Outi Hovatta; Hovatta Outi
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

8.  Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.

Authors:  Cynthia A Stuenkel; Susan R Davis; Anne Gompel; Mary Ann Lumsden; M Hassan Murad; JoAnn V Pinkerton; Richard J Santen
Journal:  J Clin Endocrinol Metab       Date:  2015-10-07       Impact factor: 5.958

9.  The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose.

Authors:  Marta Snajderova; Tonko Mardesic; Jan Lebl; Hedvika Gerzova; Leos Teslik; Jirina Zapletalova
Journal:  Horm Res       Date:  2003

10.  Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.

Authors:  Marianne Canonico; Laure Carcaillon; Geneviève Plu-Bureau; Emmanuel Oger; Archana Singh-Manoux; Pascale Tubert-Bitter; Alexis Elbaz; Pierre-Yves Scarabin
Journal:  Stroke       Date:  2016-06-02       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.